Glioma tissue (expressing IDH1 R132H/C/G mutations) and cell lines (expressing IDH1 R132H/C/G/S/L mutations) showed varying concentrations of D2HG depending on the IDH1 mutation present, with R132H associated with the lowest levels of D2HG (19, 20). Here, IDH1 is linked to central nervous system cancer.